MedPath

The effect of vitamin D supplementation in the prevention of recurrence of preeclampsia in pregnant women with a history of preeclampsia

Phase 3
Conditions
preeclampsia.
Gestational [pregnancy-induced] hypertension with significant proteinuria Excl.: superimposed pre-eclampsia (O11) O14.0 Moderate pre-eclampsia O14.1 Severe pre-eclampsia
o14.0 , o1
Registration Number
IRCT2017010131695N1
Lead Sponsor
Vice chancellor for research, Kurdistan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
142
Inclusion Criteria

Inclusion criteria : pregnancy , history of preeclampsia in a previous pregnancy , blood levels of vitamin D above 32 nanograms per milliliter
Exclusion criteria : the risk of chronic hypertension before pregnancy , chronic kidney disease associated pulmonary and cardiovascular , immunological diseases such as lupus , the uncertainty of patient cooperation in the study , immigration or study leave.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Systolic and Diastolic blood pressure. Timepoint: In initiation of study, 2 week after intervention, per 2 week to termination of pregnancy. Method of measurement: Blood pressure is measured in the sitting position by using mercury barometer.;Proteinuria. Timepoint: If there is a blood pressure greater than or equal to 140/90 mm Hg. Method of measurement: laboratory kit.
Secondary Outcome Measures
NameTimeMethod
Preeclampsia Recognition. Timepoint: After 28 weeks of pregnancy. Method of measurement: Measurement of blood pressure by using barometer, clinical symptoms and proteinuria detection by using laboratory kit.
© Copyright 2025. All Rights Reserved by MedPath